Company Profile: AKDITAL

Background

Overview

Founded in 2011 by Dr. Rochdi Talib, AKDITAL has emerged as Morocco's leading private healthcare group. The company's mission is to democratize quality healthcare, ensuring accessibility for all Moroccans. With a vision centered on patient-first care, AKDITAL emphasizes clinical excellence and superior service standards. As of 2024, the group operates 38 healthcare facilities across key Moroccan cities, representing over 20% of the country's private healthcare capacity.

Historical Milestones

2011: Inception with the Jerrada Clinic in Casablanca.

2015: Expansion of Jerrada Clinic to 100 beds.

2018: Opening of Ain Borja Clinic in Casablanca with 100 beds.

2019: Launch of three new facilities in Casablanca: CIOC, HP Ain Sebâa, and Clinique Longchamps, adding 400 beds.

2020: Capital opened to Mediterrania Capital Partners (20% stake); establishment of AKDITAL Immo to separate operational and real estate activities.

2021: Inauguration of two establishments in El Jadida with a total capacity of 220 beds; acquisition of Vinci and Atfal clinics, adding 92 beds.

2022: Opening of eight new facilities with a total capacity of 910 beds in Sidi Maarouf, Tangier (2), Agadir (2), Salé (2), and Safi; IPO in December; Aradei Group acquires a 51% stake in AKDITAL Immo.

2023: Launch of five new facilities with a combined capacity of 570 beds in Bouskoura, Mohammedia, Fès (2), and Béni Mellal.

2024: Opening of 12 new health establishments, bringing the total to 33 structures across the Kingdom.

Key Strategic Focus

Expansion and Diversification

AKDITAL's strategic focus encompasses:

National Footprint Expansion: Aiming for nationwide coverage, particularly targeting underserved cities to ensure accessible, high-quality healthcare.

Service Diversification: Broadening its portfolio to include specialized services such as interventional cardiology, critical care, and oncology.

International Expansion: Plans to extend operations into Sub-Saharan Africa and the Middle East, leveraging existing partnerships and replicating its successful model.

Financials and Funding

IPO and Capital Allocation

In December 2022, AKDITAL successfully completed its IPO on the Casablanca Stock Exchange, raising MAD 1.2 billion. The proceeds have been strategically allocated to expand the network of hospitals and clinics, enhancing the company's capacity to meet the growing healthcare demands.

Financial Performance

By 2024, AKDITAL reported a revenue of MAD 2.95 billion, marking a 55% increase from the previous year. Net income rose by 80% to MAD 314.6 million. This growth is attributed to the launch of 12 new facilities and the expansion of existing centers.

Debt and Equity

As of June 2025, AKDITAL's financial health indicators include:

Total Shareholder Equity: MAD 2.6 billion

Total Debt: MAD 1.2 billion

Debt-to-Equity Ratio: 44%

Interest Coverage Ratio: 8.8x

Cash and Short-Term Investments: MAD 322.5 million

Technological Platform and Innovation

Proprietary Technologies and Methodologies

AKDITAL integrates state-of-the-art medical technologies and innovative healthcare solutions to enhance patient care. The group's facilities are equipped with advanced diagnostic and therapeutic equipment, ensuring comprehensive and efficient treatment across various specialties.

Leadership Team

Key Executives

Dr. Rochdi Talib: Chairman and Chief Executive Officer. An anesthesiologist and intensive care specialist, Dr. Talib founded AKDITAL with a vision to elevate Morocco's healthcare standards. He has been instrumental in the group's strategic growth and expansion.

Dr. Jaouad Zakaria: Executive Vice President. Dr. Zakaria plays a pivotal role in overseeing the group's operational strategies and ensuring the delivery of high-quality healthcare services.

Ilyas El Harti: Deputy Chief Executive Officer. El Harti focuses on the group's financial strategies and corporate development initiatives.

Amal Raji: Chief Operating Officer. Raji is responsible for the day-to-day operations of AKDITAL's extensive network of healthcare facilities.

Mohamed El Bouzidi: Chief Information Officer. With a background in statistics and information technology, El Bouzidi leads the group's digital transformation and information systems.

Amine Cheikh: Director of Pharmacy and Medical Devices Procurement Center. Dr. Cheikh oversees the procurement and management of pharmaceuticals and medical devices, ensuring quality and efficiency.

Leadership Changes

In April 2025, Mediterrania Capital Partners exited its investment in AKDITAL, marking a significant transition in the company's shareholder structure. This exit reflects the successful growth and maturity of AKDITAL under the partnership.

Competitor Profile

Market Insights and Dynamics

Morocco's healthcare sector is undergoing significant transformation, driven by demographic shifts, increased health awareness, and government reforms. The private healthcare market is expanding, with AKDITAL at the forefront, benefiting from economies of scale and diverse service offerings.

Competitor Analysis

While specific competitors are not detailed in the available information, AKDITAL's rapid expansion and market share indicate a competitive edge in the private healthcare sector. The group's strategic focus on underserved regions and specialized services positions it favorably against other private healthcare providers.

Strategic Collaborations and Partnerships

AKDITAL has engaged in strategic partnerships to bolster its market position and innovation capacity. Notably, the collaboration with Mediterrania Capital Partners facilitated significant growth and operational enhancements. Additionally, the partnership with Aradei Group, which acquired a 51% stake in AKDITAL Immo, underscores the group's commitment to strategic alliances that support its expansion and service diversification.

Operational Insights

AKDITAL's strategic considerations include:

Market Position: As a leader in Morocco's private healthcare sector, AKDITAL leverages its extensive network and service diversification to maintain a competitive advantage.

Competitive Advantages: The group's focus on underserved regions, investment in advanced medical technologies, and commitment to patient-centric care distinguish it from competitors.

Strategic Opportunities and Future Directions

Looking ahead, AKDITAL aims to:

Expand Nationally: Continue increasing its presence across Morocco, particularly in underserved areas, to enhance healthcare accessibility.

Diversify Services: Introduce new specialized services to meet evolving patient needs and address gaps in the healthcare market.

Pursue International Expansion: Leverage its successful model to enter markets in Sub-Saharan Africa and the Middle East, contributing to the global improvement of healthcare standards.

Contact Information

Website: akdital.ma

LinkedIn: linkedin.com/company/akdital

Facebook: facebook.com/akdital

Instagram: instagram.com/akdital

Twitter: twitter.com/akdital